Kevin Schmid - 14 May 2026 Form 4 Insider Report for Modular Medical, Inc. (MODD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 May 2026, 18:03:09 UTC
Prior SEC filing
28 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James Sullivan, attorney-in-fact for Kevin Schmid

Key filing fact

Kevin Schmid filed Form 4 for Modular Medical, Inc. (MODD) on 18 May 2026.

Key facts

  • This page summarizes Kevin Schmid's Form 4 filing for Modular Medical, Inc. (MODD).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 18 May 2026, 18:03.

Change

  • Previous filing in this sequence was filed on 28 Apr 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001395775 Primary reporting owner

Schmid Kevin

Relationship
Chief Operating Officer
Address
C/O MODULAR MEDICAL, INC, 10740 THORNMINT ROAD, SAN DIEGO
Signature
/s/ James Sullivan, attorney-in-fact for Kevin Schmid
Signature date
18 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MODD transaction Derivative

Option to purchase common stock

Award

Transaction value
Shares
+4,674
Change %
Price
$0.000000*
Shares after
4,674
Date
14 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,674
Exercise price
$3.46
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option shall vest as to 1/3rd of the shares subject to the option on May 14, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter.

Footnote F2

In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .